ConductScience.org, home

Paper41001799

In silico Study of Novel Tryptanthrin-Based Topoisomerase Inhibitors.

Kumawat MK and 1 other. Med Chem, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. In silico Study of Novel Tryptanthrin-Based Topoisomerase Inhibitors. Papers, record 41001799. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41001799

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In silico Study of Novel Tryptanthrin-Based Topoisomerase Inhibitors.
PubMed
Journal
Med Chem
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumawat MKMukesh Kumar
2Kumar KKapilhttps://orcid.org/0000-0003-2875-2119

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
QuinazolinesMajor topic
Antineoplastic AgentsMajor topic
Topoisomerase InhibitorsMajor topic
Molecular Docking Simulation
Humans
Structure-Activity Relationship
Computer Simulation
Molecular Structure
Ligands

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128720329Recent synthetic and medicinal perspectives of tryptanthrin.Bioorg Med Chem2017https://conductscience.org/library/papers/28720329PubMed
2320255102-Phenylethanol and 2-phenylethylacetate production by nonconventional yeasts using tequila vinasses as a substrate.Biotechnol Rep (Amst)2020https://conductscience.org/library/papers/32025510PubMed
326394469[Study of Antioxidant and Membranotropic Activities of Quinazoline Alkaloid Tryptanthrin Using Different Model Systems].Biofizika2015https://conductscience.org/library/papers/26394469PubMed
432357298Discovery of Tryptanthrins as Novel Antiviral and Anti-Phytopathogenic-Fungus Agents.J Agric Food Chem2020https://conductscience.org/library/papers/32357298PubMed
532792961Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis.Front Pharmacol2020https://conductscience.org/library/papers/32792961PubMed
623543631Progress in the studies on tryptanthrin, an alkaloid of history.Arch Pharm Res2013https://conductscience.org/library/papers/23543631PubMed
723360475Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.J Nat Prod2013https://conductscience.org/library/papers/23360475PubMed
829485730Biologically active quinoline and quinazoline alkaloids part II.Med Res Rev2018https://conductscience.org/library/papers/29485730PubMed
932024909Tryptanthrin promotes keratinocyte and fibroblast responses in vitro after infection with Trichophyton benhamiae DSM6916.Sci Rep2020https://conductscience.org/library/papers/32024909PubMed
1032455240
Arene-Ruthenium(II) Complexes Containing 11H-Indeno[1,2-b]quinoxalin-11-one Derivatives and Tryptanthrin-6-oxime: Synthesis, Characterization, Cytotoxicity, and Catalytic Transfer Hydrogenation of Aryl Ketones.
ACS Omega2020https://conductscience.org/library/papers/32455240PubMed
1134735707Tryptanthrin derivatives as efficient singlet oxygen sensitizers.Photochem Photobiol Sci2022https://conductscience.org/library/papers/34735707PubMed
1220139909Cytotoxicity and reversal of multidrug resistance by tryptanthrin-derived indoloquinazolines.Acta Pharmacol Sin2010https://conductscience.org/library/papers/20139909PubMed
1336674964Discovery of Tryptanthrin and Its Derivatives and Its Activities against NSCLC In Vitro via Both Apoptosis and Autophagy Pathways.Int J Mol Sci2023https://conductscience.org/library/papers/36674964PubMed
1432945360Design, synthesis and biomedical evaluation of mostotrin, a new water soluble tryptanthrin derivative.Int J Mol Med2020https://conductscience.org/library/papers/32945360PubMed
1537895927Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37895927PubMed
1639034729A Novel Tryptanthrin Derivative D6 Induces Apoptosis and DNA Damage in Non-small-cell Lung Cancer Cells Through Regulating the EGFR Pathway.Anticancer Agents Med Chem2024https://conductscience.org/library/papers/39034729PubMed
1738665827Recent advances of tryptanthrin and its derivatives as potential anticancer agents.RSC Med Chem2024https://conductscience.org/library/papers/38665827PubMed
1837375361Novel Tryptanthrin Derivatives with Selectivity as c-Jun N-Terminal Kinase (JNK) 3 Inhibitors.Molecules2023https://conductscience.org/library/papers/37375361PubMed
1911422788Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour.Pathol Int2001https://conductscience.org/library/papers/11422788PubMed
2019887046Modulatory effects and action mechanisms of tryptanthrin on murine myeloid leukemia cells.Cell Mol Immunol2009https://conductscience.org/library/papers/19887046PubMed

See all 47 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41001799

GET https://conductscience.org/api/papers/v1/41001799/references?page=2